FDA NDC Directory · JSON-LD · Markdown

RIVASTIGMINE TARTRATE

NDC 75834-133 · HUMAN PRESCRIPTION DRUG · CAPSULE

Labeler / ManufacturerNivagen Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA203844
Dosage form / routeCAPSULE · ORAL
Active ingredientsRIVASTIGMINE TARTRATE (1.5 mg/1)
Marketing started20170904
Package count2

External sources

Source: openFDA. Public-domain (CC0).